Cell and Gene Logistics

  1. Tackling The Standardization Issue For mRNA Therapeutics 10/28/2024

    This segment features a discussion around the obstacles to establishing a standardized production pipeline for mRNA therapeutics across the industry as well as some the approaches being considered to standardize cold chain management protocols for mRNA products.

  2. Regulatory Considerations For The mRNA Platform 10/28/2024

    Joseph Barberio of Strand Therapeutics and Christian Moreno of Nutcracker Therapeutics share how their companies ensure data integrity and privacy compliance throughout R&D and manufacturing.

  3. Top Bottlenecks Facing mRNA Supply Chain 10/28/2024

    In this first segment from Cell & Gene Live, we explore the state of the mRNA therapeutics supply chain and the major bottlenecks that exist today, including non-GMP grade reagents to sourcing DNA.

  4. The Unique Challenges Of The Cell & Gene Therapy Supply Chain 10/28/2024

    Cell and gene therapies present unique logistical challenges for the supply chain, requiring careful consideration of factors like shelf life, packaging, temperature, and chain of custody.

  5. Cold Storage And Cryopreservation Animal Component Free Solutions For Short And Long Term Storage Of Cells 10/28/2024

    Explore advanced cryopreservation and cold storage solutions that ensure high cell viability and quality for both short- and long-term cell storage applications.

  6. Highlights From ARM's 2024 Meeting On The Mesa 10/25/2024

    ARM's 2024 Meeting on the Mesa has concluded. Here are a few brief highlights from this year's conference.

  7. The Way Forward: Supply Chain Solutions 10/24/2024

    Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.

  8. Cell & Gene Therapies: Avoid This Common Pitfall In Supply Chain Planning 10/24/2024

    BioPhorum members propose a Design for Supply model for cell and gene therapy supply chain planning. Don't let it take a backseat until the later stages of the product life cycle.

  9. What's Next After FDA's DSCSA Extension? 10/18/2024

    Facing growing pressure from industry and Congress, FDA extended its enforcement deadline yet again, which has important implications for manufacturers.

  10. Data Quality Issues At The Heart Of FDA's DSCSA Troubles 10/18/2024

    Industry still struggles to manage complex data requirements, which forced the FDA to once again delay enforcement of the Drug Supply Chain Security Act.